95 results
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
with regulatory standards and requirements and insider trading.
We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees … to the FDA and non-U.S. regulators, to comply with healthcare fraud and abuse laws and regulations in the United States and abroad, to report financial
424B3
029nl0bt
8 Mar 24
Prospectus supplement
4:06pm
424B3
8h7bv
8 Mar 24
Prospectus supplement
4:04pm
8-K
EX-10.1
wk0u5dc sgjir9rn
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
424B4
2rd0k50
6 Mar 24
Prospectus supplement with pricing info
5:07pm
424B3
37jint5
4 Mar 24
Prospectus supplement
5:27pm
424B3
128k xjerbbeb
31 Jan 24
Prospectus supplement
12:00am
8-K
EX-10.1
v7lxxaya
30 Jan 24
Entry into a Material Definitive Agreement
4:05pm
424B3
cs45nke q403ob
9 Nov 23
Prospectus supplement
5:15pm
424B3
ail v5q34w7eppwzj0
14 Sep 23
Prospectus supplement
4:38pm